Moderna, Inc. (MRNA) vs Regeneron Pharmaceuticals, Inc. (REGN)

• Moderna, Inc. MRNA 260.20 ▲ +7.76%
• Regeneron Pharmaceuticals, Inc. REGN 907.36 ▲ +0.49%

Moderna, Inc. and Regeneron Pharmaceuticals, Inc. are both Biotechnology companies. Moderna, Inc. and Regeneron Pharmaceuticals, Inc. are of similar size ($96.4B and $93.4B). Moderna, Inc. has negative trailing earnings, so its P/E is not meaningful; Regeneron Pharmaceuticals, Inc. trades at 19.2×. Regeneron Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 18.6% against −27.6%. Regeneron Pharmaceuticals, Inc. has the higher net margin (28.5% vs −141.4%) and the higher return on invested capital (11.6% vs −93.5%). Across the 19 metrics below, Regeneron Pharmaceuticals, Inc. leads on 17 and Moderna, Inc. on 2.